No Advisory Committee Meeting Currently Planned to Review the ApplicationIf approved, 1st Gene Therapy in U.S. for the Treatment of Any Type of HemophiliaFDA Also Accepts Premarket Approval (PMA) Application for Companion Diagnostic Test, a 1st for a G… […]
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2020 /PRNewswire/ — VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet … […]
– Onvansertib demonstrates efficacy in Zytiga®-resistant metastatic castration-resistant prostate cancer (mCRPC) across known androgen receptor resistance mechanisms- Onvansertib-induced decreases in circulating tumor cells (CTCs) is a surrogate for ef… […]
SAN JOSE, Calif., Feb. 13, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood… […]
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results for the fourth quarter and full year … […]
SAN FRANCISCO, Feb. 11, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that one of the largest CDMOs in southern Europe has chosen ValGenesis’s 100% paperless VL… […]
NEWARK, Calif., Feb. 7, 2020 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that the Company will present preclinical data on PN-943, the Company’s oral, gut-restricted, alpha-4-beta-7 inhibitor candidate therapeutic, a… […]
Acquiring proprietary drugs to control CODA engineered receptors advances the Company’s gene therapy-mediated chemogenetic platform toward the clinic
SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 /PRNewswire/ — CODA Biotherapeutics, Inc., a preclinical-… […]
Brian R. Mueller, Chief Accounting Officer and 17-year company veteran, named acting CFODan Spiegelman steps down as CFO; will assist with transition until September 1, 2020
SAN RAFAEL, Calif., Feb. 3, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc… […]
– Jim Wassil appointed Chief Operating Officer
FOSTER CITY, Calif., Jan. 30, 2020 /PRNewswire/ — SutroVax, a biopharmaceutical company dedicated to developing best-in-class conjugate vaccines and novel complex antigen-based vaccines designed to… […]
© 2019 San Francisco Biotechnology Network
